Treatment for osteoarthritis includes a mixture of Diacerin (DIA), Glucosamine sulphate (GLU), and Methyl sulfonyl methane (MSM). Methyl sulfonyl methane functions as a dietary supplement, whereas Diacerin and Glucosamine sulphate stimulate proteoglycan synthesis. The simultaneous quantification of DIA, GLU, and MSM in pharmaceutical dosage forms has been developed using the RP-HPLC method. With a flow rate of 0.9 mL/min, chromatography was performed on an Agilent C18 150x 4.6, 5.0 mm column. pH 3.0 0.1 percent orthophosphoric acid buffer and 60:40 (percent v/v) acetonitrile made up the mobile phase. 2.233, 2.823, and 3.286 minutes were found to be the retention times for DIA, GLU, and MSM, respectively. In the concentration ranges of 2.5-15 g/mL (R2 = 0.999) for DIA, 37.5-225 g/mL (R2 = 0.999) for GLU, and 12.5-75 g/mL (R2 = 0.999) for MSM, the approach follows Beer's law. Diacerin's LOD and LOQ were discovered to be 0.05 g/mL and 0.14 g/mL, Glucosamine sulphate's LOD and LOQ were 0.90 g/mL and 2.73 g/mL, and Methyl sulfonyl methane's LOD and LOQ were 0.88 g/mL and 2.67 g/mL, respectively. Recovery studies in the dose form at three concentration levels were used to assess the accuracy of the established approach. The mean percent recovery for DIA, GLU, and MSM was determined to be 99.62 percent, 99.62 percent, and 99.94 percent, respectively. The approach was used to calculate the dosage of Orcerin GM tablets. As per ICH requirements, the devised approach has been statistically validated. As a result, the chromatographic method developed for the estimation has been described as rapid, simple, precise, accurate, robust, and reliable, and it can be used for routine analysis in research institutions, quality control departments in industries, approved testing laboratories, biopharmaceutics and bioequivalence studies, and clinical pharmacokinetic studies.
Read full abstract